Brain science on chronic fatigue

Japan Medical Association Journal

Volumn 49, Issue 1, 2006, Pages 19-26

  Watanabe, Yasuyoshi ^a   Kuratsune, Hirohiko ^a,b  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KANSAI UNIVERSITY OF WELFARE SCIENCES   (Japan)

Author keywords

Chronic fatigue; Cytokines; Genetic background; Neurotransmitters; Social stress events

Indexed keywords

AUTOANTIBODY; CYTOKINE; NEUROTRANSMITTER;

BORNA DISEASE; BRAIN DYSFUNCTION; CENTRAL NERVOUS SYSTEM INFECTION; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHESIS; IMMUNOPATHOLOGY; JAPAN; NEUROPHYSIOLOGY; PATHOGENESIS; PATHOPHYSIOLOGY; PSYCHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOCIAL PROBLEM; VIRUS INFECTION;

EID: 33645748470     PISSN: 13468650     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Holmes GP, Kaplan JE, Gantz NM, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988;108: 387-389.
2. Holmes TH, Rahe RH. The social readjustment rating scale. J Psychosom Res. 1967;11:213-218.
3. Narita M, Nishigami N, Narita N, et al. Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun. 2003;311(2):264-266.
4. Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol. 1990;28(6):1403-1410.
5. Bennett AL, Chao CC, Hu S, et al. Elevation of bioactive transforming growth factor-beta in serum from patients with chronic fatigue syndrome. J Clin Immunol. 1997;17(2):160-166.
6. Moss RB, Mercandetti A, Vojdani A. TNF-alpha and chronic fatigue syndrome. J Clin Immunol. 1999;19(5):314-316.
7. Suhadolnik RJ, Reichenbach NL, Hitzges P, et al.: Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis. 1994;18(Suppl 1): S96-104.
8. Ikuta K, Yamada T, Shimomura T, et al. Diagnostic evaluation of 2′,5′-oligoadenylate synthetase activities and antibodies against Epstein-Barr virus and Coxiella Burnetii in patients with chronic fatigue syndrome in Japan. Microbes Infect. 2003;5(12):1096-1102.
9. Demettre E, Bastide L, D'Haese A, et al. Ribonuclease L proteolysis in peripheral blood mononuclear cells of chronic fatigue syndrome patients. J Biol Chem. 2002;277(38):35746-35751.
10. Katafuchi T, Kondo T, Yasaka T, Kubo K, Take S, Yoshimura M. Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running wheel activity and brain interferon-alpha mRNA in rats: a model for immunologically induced fatigue. Neuroscience. 2003;120(3):837-845.
11. Inoue K, Yamazaki H, Manabe Y, Fukuda C, Hanai K, Fushiki T. Transforming growth factor-beta activated during exercise in brain depresses spontaneous motor activity of animals. Relevance to central fatigue. Brain Res. 1999;846(2):145-153.
12. Stankovic AK, Dion LD, Parker CR Jr. Effects of transforming growth factor-beta on human fetal adrenal steroid production. Mol Cell Endocrinol. 1994;99(2):145-151.
13. Chiu KM, Schmidt MJ, Shug AL, Binkley N, Gravenstein S. Effect of dehydroepiandrosterone sulfate on carnitine acetyl transferase activity and L-carnitine levels in oophorectomized rats. Biochim Biophys Acta. 1997;1344(3):201-209.
14. Kuratsune H, Yamaguti K, Sawada M, et al. Dehydroepiandrosterone sulfate deficiency in chronic fatigue syndrome. Int J Mol Med. 1998;1:143-146.
15. Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome. Clin Infect Dis. 1994;18(Suppl 1):S62-67.
16. Tanaka S, Kuratsune H, Hidaka Y, et al. Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med. 2003;12:225-230.
17. Levy JA. Viral studies of chronic fatigue syndrome. Clin Infect Dis. 1994;18(Suppl 1):S117-120.
18. Ablashi DV, Eastman HB, Owen CB, et al. Frequent HHV-6 reactivation in multiple sclerosis (MS) and chronic fatigue syndrome (CFS) patients. J Clin Virol. 2000;16(3):179-191.
19. Vojdani A, Choppa PC, Tagle C, Andrin R, Samimi B, Lapp CW. Detection of Mycoplasma genus and Mycoplasma fermentans by PCR in patients with chronic fatigue syndrome. FEMS Immunol Med Microbiol. 1998;22(4):355-365.
20. Demitrack MA, Dale JK, Straus SE, et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab. 1991; 73(6):1224-1234.
21. Roberts AD, Wessely S, Chalder T, Papadopoulos A, Cleare AJ. Salivary cortisol response to awakening in chronic fatigue syndrome. Br J Psychiatry. 2004;184:136-141.
22. Gaab J, Engert V, Heitz V, Schad T, Schurmeyer TH, Ehlert U. Associations between neuroendocrine responses to the insulin tolerance test and patient characteristics in chronic fatigue syndrome. J Psychosom Res. 2004;56(4):419-424.
23. Gaab J, Huster D, Peisen R, et al. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom Med. 2002;64(2):311-318.
24. Yamaguti K, Kuratsune H, Watanabe Y, et al. Acylcarnitine metabolism during fasting and after refeeding. Biochem Biophys Res Commun. 1996;225:740-746.
25. Kuratsune H, Yamaguti K, Lindh G, et al. Brain regions involved in fatigue sensation: Reduced acetylcarnitine uptake into the brain. Neuroimage. 2002;17(3):1256-1265.
26. Ichise M, Salit IE, Abbey SE, et al. Assessment of regional cerebral perfusion by 99Tcm-HMPAO SPECT in chronic fatigue syndrome. Nucl Med Commun. 1992;13:767-772.
27. Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. QJM. 1995;88:767-773.
28. Fischler B, D'Haenen H, Cluydts R, et al. Comparison of 99mTc HMPAO SPECT scan between chronic fatigue syndrome, major depression and healthy controls: an exploratory study of clinical correlates of regional cerebral blood flow. Neuropsychobiology. 1996;34:175-183.
29. Okada T, Tanaka M, Kuratsune H, Watanabe Y, Sadato N. Mechanisms underlying fatigue: a voxel-based morphometric study of chronic fatigue syndrome. BMC Neurol. 2004;4:14.
30. Yamamoto S, Ouchi Y, Onoe H, et al. Reduction of serotonin transporters of patients with chronic fatigue syndrome. Neuroreport. 2004;15:2571-2574.
31. Oliff A, Defeo-Jones D, Boyer M, et al. Tumors secreting human TNF/ cachectin induce cachexia in mice. Cell. 1987;50(4):555-563.